Arnau Casanovas-Massana
Overview
Explore the profile of Arnau Casanovas-Massana including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
64
Citations
5368
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhu K, Hill C, Muirhead A, Basu M, Brown J, Brinton M, et al.
Water Res
. 2023 Jun;
241:120116.
PMID: 37270953
During the 2015-2016 Zika virus (ZIKV) epidemic in the Americas, serological cross-reactivity with other flaviviruses and relatively high costs of nucleic acid testing in the region hindered the capacity for...
2.
Dogonyaro B, van Heerden H, Potts A, Fasina F, Casanovas-Massana A, Kolo F, et al.
Pathogens
. 2023 May;
12(5).
PMID: 37242336
was investigated in kidneys ( = 305) from slaughtered livestock in the Gauteng Province abattoirs, South Africa, using a culture medium to isolate , followed by the qPCR to detect...
3.
Lapidus S, Liu F, Casanovas-Massana A, Dai Y, Huck J, Lucas C, et al.
Sci Rep
. 2022 Dec;
12(1):22175.
PMID: 36550362
Sero-surveillance can monitor and project disease burden and risk. However, SARS-CoV-2 antibody test results can produce false positive results, limiting their efficacy as a sero-surveillance tool. False positive SARS-CoV-2 antibody...
4.
Bernard-Raichon L, Venzon M, Klein J, Axelrad J, Zhang C, Sullivan A, et al.
Nat Commun
. 2022 Nov;
13(1):5926.
PMID: 36319618
Although microbial populations in the gut microbiome are associated with COVID-19 severity, a causal impact on patient health has not been established. Here we provide evidence that gut microbiome dysbiosis...
5.
George S, Pal A, Gagnon J, Timalsina S, Singh P, Vydyam P, et al.
Kidney360
. 2022 Apr;
2(6):924-936.
PMID: 35373072
Background: SARS-CoV-2 infection has, as of April 2021, affected >133 million people worldwide, causing >2.5 million deaths. Because the large majority of individuals infected with SARS-CoV-2 are asymptomatic, major concerns...
6.
Venzon M, Bernard-Raichon L, Klein J, Axelrad J, Zhang C, Hussey G, et al.
bioRxiv
. 2022 Mar;
PMID: 35262080
The microbial populations in the gut microbiome have recently been associated with COVID-19 disease severity. However, a causal impact of the gut microbiome on COVID-19 patient health has not been...
7.
Collins M, Potter G, Hitchings M, Butler E, Wiles M, Kennedy J, et al.
Trials
. 2022 Mar;
23(1):185.
PMID: 35236394
Background: Arboviruses transmitted by Aedes aegypti including dengue, Zika, and chikungunya are a major global health problem, with over 2.5 billion at risk for dengue alone. There are no licensed...
8.
Kuchroo M, Huang J, Wong P, Grenier J, Shung D, Tong A, et al.
Nat Biotechnol
. 2022 Mar;
40(5):681-691.
PMID: 35228707
As the biomedical community produces datasets that are increasingly complex and high dimensional, there is a need for more sophisticated computational tools to extract biological insights. We present Multiscale PHATE,...
9.
Unterman A, Sumida T, Nouri N, Yan X, Zhao A, Gasque V, et al.
Nat Commun
. 2022 Jan;
13(1):440.
PMID: 35064122
Dysregulated immune responses against the SARS-CoV-2 virus are instrumental in severe COVID-19. However, the immune signatures associated with immunopathology are poorly understood. Here we use multi-omics single-cell analysis to probe...
10.
Haynes W, Kamath K, Bozekowski J, Baum-Jones E, Campbell M, Casanovas-Massana A, et al.
Commun Biol
. 2021 Nov;
4(1):1317.
PMID: 34811480
As Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) continues to spread, characterization of its antibody epitopes, emerging strains, related coronaviruses, and even the human proteome in naturally infected patients can...